‘What You See is All There is’: The Importance of Heuristics in Cost-Benefit Analysis (CBA) and Social Return on Investment (SROI) in the Evaluation of Public Health Interventions
Author
Abstract
Suggested Citation
DOI: 10.1007/s40258-021-00653-5
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Sabina Sanghera & Emma Frew & Tracy Roberts, 2015. "Adapting the CHEERS Statement for Reporting Cost-Benefit Analysis," PharmacoEconomics, Springer, vol. 33(5), pages 533-534, May.
- Cookson, R. & Claxton, K. eds, 2012. "The Humble Economist: Tony Culyer on Health, Health Care and Social Decision Making," Monographs, Office of Health Economics, number 000140.
- Weimer,David L., 2017.
"Behavioral Economics for Cost-Benefit Analysis,"
Cambridge Books,
Cambridge University Press, number 9781316647660, January.
- Weimer,David L., 2017. "Behavioral Economics for Cost-Benefit Analysis," Cambridge Books, Cambridge University Press, number 9781107197350, November.
- Birch, Stephen & Gafni, Amiram, 1992. "Cost effectiveness/utility analyses : Do current decision rules lead us to where we want to be?," Journal of Health Economics, Elsevier, vol. 11(3), pages 279-296, October.
- McIntosh, Emma & Clarke, Philip & Frew, Emma & Louviere, Jordan (ed.), 2010. "Applied Methods of Cost-Benefit Analysis in Health Care," OUP Catalogue, Oxford University Press, number 9780199237128.
- Rhiannon Tudor Edwards, 2001. "Paradigms and research programmes: is it time to move from health care economics to health economics?," Health Economics, John Wiley & Sons, Ltd., vol. 10(7), pages 635-649, October.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Spencer, Anne & Rivero-Arias, Oliver & Wong, Ruth & Tsuchiya, Aki & Bleichrodt, Han & Edwards, Rhiannon Tudor & Norman, Richard & Lloyd, Andrew & Clarke, Philip, 2022. "The QALY at 50: One story many voices," Social Science & Medicine, Elsevier, vol. 296(C).
- Abdelaziz Abdalla Al Owais, 2024. "Identifying the Internal and External Pressures of Quantifying the Impacts of Sustainability-Oriented Innovation," International Review of Management and Marketing, Econjournals, vol. 14(6), pages 131-142, October.
- Cristian Bricicaru & Ioana Natalia Beleiu, 2022. "Cost-Benefit Analysis of Road Infrastructure Projects," REVISTA DE MANAGEMENT COMPARAT INTERNATIONAL/REVIEW OF INTERNATIONAL COMPARATIVE MANAGEMENT, Faculty of Management, Academy of Economic Studies, Bucharest, Romania, vol. 23(1), pages 150-162, March.
- Abraham Makanjuola & Mary Lynch & Ned Hartfiel & Andrew Cuthbert & Rhiannon Tudor Edwards, 2023. "Prevention of Poor Physical and Mental Health through the Green Social Prescribing Opening Doors to the Outdoors Programme: A Social Return on Investment Analysis," IJERPH, MDPI, vol. 20(12), pages 1-18, June.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Don Husereau & Michael Drummond & Stavros Petrou & Dan Greenberg & Josephine Mauskopf & Federico Augustovski & Andrew Briggs & David Moher & Elizabeth Loder & Chris Carswell, 2015. "Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration," PharmacoEconomics, Springer, vol. 33(5), pages 535-536, May.
- A. Gafni & S. D. Walter & S. Birch & P. Sendi, 2008. "An opportunity cost approach to sample size calculation in cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 17(1), pages 99-107, January.
- McKenna, Claire & Chalabi, Zaid & Epstein, David & Claxton, Karl, 2010.
"Budgetary policies and available actions: A generalisation of decision rules for allocation and research decisions,"
Journal of Health Economics, Elsevier, vol. 29(1), pages 170-181, January.
- Claire McKenna & Zaid Chalabi & David Epstein & Karl Claxton, 2008. "Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions," Working Papers 044cherp, Centre for Health Economics, University of York.
- Adam Oliver, 2005. "The English National Health Service: 1979‐2005," Health Economics, John Wiley & Sons, Ltd., vol. 14(S1), pages 75-99, September.
- Mercy G. Mugo & Peterson J. Muriithi, 2018. "Cost Effectiveness Analysis of Family Planning Provision in Kenya," Journal of African Development, African Finance and Economic Association (AFEA), vol. 20(1), pages 13-22.
- Richard Cookson & Owen Cotton-Barrett & Matthew Adler & Miqdad Asaria & Toby Ord, 2016. "Years of good life based on income and health: Re-engineering cost-benefit analysis to examine policy impacts on wellbeing and distributive justice," Working Papers 132cherp, Centre for Health Economics, University of York.
- Morton, Alec, 2014. "Aversion to health inequalities in healthcare prioritisation: A multicriteria optimisation perspective," Journal of Health Economics, Elsevier, vol. 36(C), pages 164-173.
- Amiram Gafni & Stephen Walter & Stephen Birch, 2013. "Uncertainty And The Decision Maker: Assessing And Managing The Risk Of Undesirable Outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 22(11), pages 1287-1294, November.
- Brian Nolan, 1994. "Affordability versus Quality, Effectiveness and Equity in Health Care: Is there a Trade-Off?," Papers WP055, Economic and Social Research Institute (ESRI).
- Afschin Gandjour, 2011. "Germany’s decision rule for setting ceiling prices of drugs," Applied Health Economics and Health Policy, Springer, vol. 9(2), pages 65-71, March.
- Hoel, Michael, 2009. "Efficient use of health care resources: The interaction between improved health and reduced health related income loss," HERO Online Working Paper Series 2001:9, University of Oslo, Health Economics Research Programme.
- Bernie J. O'Brien & Kirsten Gertsen & Andrew R. Willan & A. Faulkner, 2002. "Is there a kink in consumers' threshold value for cost‐effectiveness in health care?," Health Economics, John Wiley & Sons, Ltd., vol. 11(2), pages 175-180, March.
- Stéphane Verguet & Jane J. Kim & Dean T. Jamison, 2016. "Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial," PharmacoEconomics, Springer, vol. 34(9), pages 913-923, September.
- Emma Frew, 2017. "Aligning Health Economics Methods to Fit with the Changing World of Public Health," Applied Health Economics and Health Policy, Springer, vol. 15(3), pages 287-289, June.
- Nicholas Graves & Mary Courtney & Helen Edwards & Anne Chang & Anthony Parker & Kathleen Finlayson, 2009. "Cost-Effectiveness of an Intervention to Reduce Emergency Re-Admissions to Hospital among Older Patients," PLOS ONE, Public Library of Science, vol. 4(10), pages 1-9, October.
- Carmen Herrero & Juan Moreno-Ternero, 2008.
"Opportunity analysis of newborn screening programs,"
Review of Economic Design, Springer;Society for Economic Design, vol. 12(4), pages 259-277, December.
- Juan D. Moreno Ternero & Carmen Herrero Blanco, 2005. "Opportunity Analysis Of Newborn Screening Programs," Working Papers. Serie AD 2005-02, Instituto Valenciano de Investigaciones Económicas, S.A. (Ivie).
- HERRERO, Carmen & MORENO-TERNERO, Juan D., 2007. "Opportunity analysis of newborn screening programs," LIDAM Discussion Papers CORE 2007029, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- HERRERO, Carmen & MORENO-TERNERO, Juan D., 2009. "Opportunity analysis of newborn screening programs," LIDAM Reprints CORE 2109, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- Salkeld, Glenn & Davey, Peter & Arnolda, Gaston, 1995. "A critical review of health-related economic evaluations in Australia: implications for health policy," Health Policy, Elsevier, vol. 31(2), pages 111-125, February.
- Joanne Lord & George Laking & Alastair Fischer, 2006. "Non‐linearity in the cost‐effectiveness frontier," Health Economics, John Wiley & Sons, Ltd., vol. 15(6), pages 565-577, June.
- Pedram Sendi, 2021. "Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve," PharmacoEconomics, Springer, vol. 39(2), pages 161-169, February.
- Elamin H. Elbasha, 2005. "Risk aversion and uncertainty in cost‐effectiveness analysis: the expected‐utility, moment‐generating function approach," Health Economics, John Wiley & Sons, Ltd., vol. 14(5), pages 457-470, May.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:aphecp:v:19:y:2021:i:5:d:10.1007_s40258-021-00653-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.